000			01662 a2200469 4500
005			20250516030854.0
264		0	_c20110909
008			201109s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-10-0997 _2doi
040			_aNLM _beng _cNLM
100	1		_aSnoeks, Thomas J A
245	0	0	_a2-methoxyestradiol analogue ENMD-1198 reduces breast cancer-induced osteolysis and tumor burden both in vitro and in vivo. _h[electronic resource]
260			_bMolecular cancer therapeutics _cMay 2011
300			_a874-82 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBone Neoplasms _xpathology
650	0	4	_aBone Resorption _xdrug therapy
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aEstrenes _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aOsteoclasts _xdrug effects
650	0	4	_aOsteolysis _xdrug therapy
650	0	4	_aPregnancy
650	0	4	_aTumor Burden _xdrug effects
700	1		_aMol, Isabel M
700	1		_aQue, Ivo
700	1		_aKaijzel, Eric L
700	1		_aLöwik, Clemens W G M
773	0		_tMolecular cancer therapeutics _gvol. 10 _gno. 5 _gp. 874-82
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-10-0997 _zAvailable from publisher's website
999			_c20692659 _d20692659